FourThought Financial Partners’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-750
Closed -$213K 503
2025
Q4
$213K Sell
750
-50
-6% -$15.6K 0.02% 441
2025
Q3
$247K Sell
800
-5,878
-88% -$1.84M 0.02% 411
2025
Q2
$2.1M Buy
6,678
+563
+9% +$162K 0.21% 98
2025
Q1
$1.61M Sell
6,115
-177
-3% -$47.9K 0.17% 106
2024
Q4
$1.64M Sell
6,292
-123
-2% -$31K 0.17% 110
2024
Q3
$1.49M Buy
6,415
+48
+0.8% +$9.86K 0.18% 93
2024
Q2
$1.28M Buy
6,367
+444
+7% +$80K 0.17% 94
2024
Q1
$1.02M Buy
5,923
+1,462
+33% +$273K 0.12% 127
2023
Q4
$968K Buy
4,461
+61
+1% +$10.5K 0.12% 128
2023
Q3
$702K Buy
4,400
+1,890
+75% +$423K 0.1% 148
2023
Q2
$724K Buy
2,510
+32
+1% +$9.72K 0.1% 149
2023
Q1
$790K Buy
2,478
+22
+0.9% +$6.52K 0.11% 137
2022
Q4
$723K Buy
+2,456
New +$677K 0.1% 149

Other funds holding PODD

FourThought Financial Partners's PODD Position: Q1 2026 in Review

FourThought Financial Partners sold out of Insulet (PODD) in Q1 2026, closing a stake of 750 shares — an estimated $213K sold.

FourThought Financial Partners first reported a position in PODD in Q4 2022 and held it in 13 quarters. The position peaked at $2.1M in Q2 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • FourThought Financial Partners reported no remaining Insulet position as of Q1 2026 after selling out during the quarter.
  • FourThought Financial Partners sold 750 Insulet shares in Q1 2026, an estimated $213K.
  • FourThought Financial Partners first reported a position in Insulet in Q4 2022 and held it in 13 quarters.
  • FourThought Financial Partners's Insulet position peaked at $2.1M in Q2 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on FourThought Financial Partners's 13F filing for Q1 2026, filed 7 May 2026.